Patents Assigned to IKFE
  • Biomarkers for Cardiodiabetes
    Publication number: 20160291011
    Abstract: The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.
    Type: Application
    Filed: November 4, 2015
    Publication date: October 6, 2016
    Applicant: IKFE lnstitut fur Klinische Forschung und Entwicklung GMBH
    Inventors: Andreas PFUETZNER, Thomas FORST
  • Method of Treating a Subject According to Biomarkers for Insulin Resistance
    Publication number: 20150219639
    Abstract: The invention provides compositions and methods for determining insulin resistance and/or pancreatic ?-cell dysfunction in a subject. The invention also provides compositions and methods for treating a subject according to the insulin resistance and/or pancreatic ?-cell dysfunction in the subject.
    Type: Application
    Filed: January 8, 2015
    Publication date: August 6, 2015
    Applicant: IKFE Institut fur Klinische Forschung und Entwicklung GMBH
    Inventors: Andreas PFUETZNER, Thomas Forst
  • Biomarkers for Cardiodiabetes
    Publication number: 20130210718
    Abstract: The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.
    Type: Application
    Filed: January 24, 2013
    Publication date: August 15, 2013
    Applicant: IKFE Institut fur Klinische Forschung und Entwicklung GMBH
    Inventor: IKFE Institut fur Klinische Forschung und Entwicklung GMBH
  • Method of Treating a Subject According to Biomarkers for Insulin Resistance
    Publication number: 20130137632
    Abstract: The invention provides compositions and methods for determining insulin resistance and/or pancreatic ?-cell dysfunction in a subject. The invention also provides compositions and methods for treating a subject according to the insulin resistance and/or pancreatic ?-cell dysfunction in the subject.
    Type: Application
    Filed: November 6, 2012
    Publication date: May 30, 2013
    Applicant: IKFE Institut fur Klinische Forschung und Entwicklung GMBH
    Inventors: Andreas Pfuetzner, Thomas Forst
  • Biomarkers for cardiodiabetes
    Patent number: 8383585
    Abstract: The invention provides compositions and methods for determining cardiodiabetes status in a subject. The invention also provides compositions and methods for treating a subject experiencing cardiodiabetes.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: February 26, 2013
    Assignee: IKFE Institut fur Klinische Forschung und Entwicklung GmbH
    Inventors: Andreas Pfuetzner, Thomas Forst
  • Method of treating a subject according to biomarkers for insulin resistance
    Patent number: 8329647
    Abstract: The invention provides compositions and methods for determining insulin resistance and/or pancreatic ?-cell dysfunction in a subject. The invention also provides compositions and methods for treating a subject according to the insulin resistance and/or pancreatic ?-cell dysfunction in the subject.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: December 11, 2012
    Assignee: IKFE Institut fur Klinische Forschung und Entwicklung GmbH
    Inventors: Andreas Pfuetzner, Thomas Forst
  • Biomarkers for insulin sensitizer drug response
    Publication number: 20110118134
    Abstract: The invention provides compositions and methods for determining insulin sensitizer drug response in a subject. The invention also provides compositions and methods for treating a subject according to insulin sensitizer drug response.
    Type: Application
    Filed: December 11, 2009
    Publication date: May 19, 2011
    Applicant: IKFE GmbH
    Inventors: Andreas PFuetzner, Thomas Forst
  • Biomarkers for Atherosclerosis
    Publication number: 20100256196
    Abstract: The invention provides compositions and methods for defining the state of atherosclerotic degeneration processes for the purposes of detection, severity assessment, monitoring and treatment. The states of atherosclerotic degeneration processes are identified by means of a biomarker panel particularly suited for detecting atherosclerotic degeneration processes. The simultaneous use of multiple markers with independent classification power will increase the performance of the panel in identifying atherosclerosis compared to other panels.
    Type: Application
    Filed: December 4, 2009
    Publication date: October 7, 2010
    Applicant: IKFE
    Inventors: Andreas Pfuetzner, Thomas Forst, Alexander Weise